Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 3/20 | 0.58 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.58 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.58 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.58 |
| ▸ | TNKS | O95271 | 1/20 | 0.58 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 7/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.54 |
| ▸ | PGR | P06401 | 2/20 | 0.54 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4407258 | 1.00 | HDAC3 (0.58) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694657 | 0.92 | HDAC2 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694655 | 0.92 | HDAC2 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694646 | 0.87 | TNFRSF1A (0.56) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694796 | 0.87 | MAPT (0.56) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694798 | 0.87 | MAPT (0.56) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694639 | 0.87 | CYP1A2 (0.51) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694641 | 0.87 | CYP1A2 (0.51) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694645 | 0.87 | TNFRSF1A (0.56) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL5694751 | 0.82 | ESR1 (0.48) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584310-A1 | H-BORON NITRIDE AND POLYCYCLIC-OLEFINIC POLYMER CONTAINING OLEFINIC FUNCTIONALITY FOR FORMING LOW-LOSS FILMS HAVING IMPROVED DIELECTRIC AND THERMAL PROPERTIES | Promerus, LLC (US) | 2025-07-16 | — | — | EP | claimed |
| EP-4584324-A1 | FLAME RETARDANT COMPOSITIONS CONTAINING POLYCYCLIC-OLEFINIC POLYMER WITH OLEFINIC FUNCTIONALITY FOR FORMING LOW-LOSS FILMS HAVING IMPROVED DIELECTRIC AND THERMAL PROPERTIES | Promerus, LLC (US) | 2025-07-16 | — | — | EP | claimed |
| CN-115433451-B | High-speed low-loss resin composition and application thereof | 郴州功田电子陶瓷技术有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118325487-B | Anisotropic conductive adhesive and anisotropic conductive adhesive film connecting piece using same | 南通德聚半导体材料有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-115873406-B | Modified BT resin and preparation method thereof | 哈尔滨工业大学（深圳） | 2024-07-30 | — | — | CN | claimed |
| US-20240110038-A1 | h-BORON NITRIDE AND POLYCYCLIC-OLEFINIC POLYMER CONTAINING OLEFINIC FUNCTIONALITY FOR FORMING LOW-LOSS FILMS HAVING IMPROVED DIELECTRIC AND THERMAL PROPERTIES | PROMERUS, LLC (US) | 2024-04-04 | — | — | US | claimed |
| US-20240110003-A1 | FLAME RETARDANT COMPOSITIONS CONTAINING POLYCYCLIC-OLEFINIC POLYMER WITH OLEFINIC FUNCTIONALITY FOR FORMING LOW-LOSS FILMS HAVING IMPROVED DIELECTRIC AND THERMAL PROPERTIES | PROMERUS, LLC (US) | 2024-04-04 | — | — | US | claimed |
| WO-2024054553-A1 | H-BORON NITRIDE AND POLYCYCLIC-OLEFINIC POLYMER CONTAINING OLEFINIC FUNCTIONALITY FOR FORMING LOW-LOSS FILMS HAVING IMPROVED DIELECTRIC AND THERMAL PROPERTIES | PROMERUS, LLC (US) | 2024-03-14 | — | — | WO | claimed |
| WO-2024054557-A1 | FLAME RETARDANT COMPOSITIONS CONTAINING POLYCYCLIC-OLEFINIC POLYMER WITH OLEFINIC FUNCTIONALITY FOR FORMING LOW-LOSS FILMS HAVING IMPROVED DIELECTRIC AND THERMAL PROPERTIES | PROMERUS, LLC (US) | 2024-03-14 | — | — | WO | claimed |
| CN-115286917-B | High-speed low-consumption resin composition containing benzocyclobutene resin and application thereof | 郴州功田电子陶瓷技术有限公司 | 2024-02-02 | — | — | CN | claimed |
| EP-1812017-A2 | OPHTHAMOLOGICAL DRUGS | Duke University (US) | 2007-08-01 | — | — | EP | claimed |
| US-20060135609-A1 | Ophthamological drugs | DUKE UNIVERSITY (US) | 2006-06-22 | — | — | US | claimed |
| WO-2006047466-A2 | OPHTHAMOLOGICAL DRUGS | DUKE UNIVERSITY (US) | 2006-05-04 | — | — | WO | claimed |
| EP-1094055-B1 | NOVEL VINYLBENZENE DERIVATIVES | SANTEN PHARMACEUTICAL CO LTD (JP) | 2006-04-26 | — | — | EP | claimed |
| US-6329547-B1 | USEFUL AS THERAPEUTIC AGENTS FOR GLAUCOMA | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2001-12-11 | — | — | US | claimed |
| EP-1094055-A1 | NOVEL VINYLBENZENE DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2001-04-25 | — | — | EP | claimed |
| US-20260146157-A1 | RESIN COMPOSITION AND ARTICLE MADE THEREFROM | Elite Material Co., Ltd. (TW) | 2026-05-28 | — | — | US | disclosed |
| US-20260146156-A1 | RESIN COMPOSITION AND ARTICLE MADE THEREFROM | ELITE ELECTRONIC MATERIAL (KUNSHAN) CO., LTD. (CN) | 2026-05-28 | — | — | US | disclosed |
| US-6329547-B1 | USEFUL AS THERAPEUTIC AGENTS FOR GLAUCOMA | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2001-12-11 | — | — | US | disclosed |
| EP-1094055-A1 | NOVEL VINYLBENZENE DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2001-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135609-A1 | Ophthamological drugs | QDPR, PTGIR, PDE6C | HDAC3 2977/4885HDAC4 1825/4885HDAC1 3945/4885 |
| US-20260146156-A1 | RESIN COMPOSITION AND ARTICLE MADE THEREFROM | PRPF6, ARCN1, PCNA | HDAC3 4062/4885HDAC4 3232/4885HDAC1 2007/4885 |
| US-20260146157-A1 | RESIN COMPOSITION AND ARTICLE MADE THEREFROM | CAD, PRPF6, CDC73 | HDAC3 4455/4885HDAC4 3984/4885HDAC1 3770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.